Infectious Disease In Vitro Diagnostics Market

Home Healthcare And Pharmaceutical Infectious Disease In Vitro Diagnostics Market

Infectious Disease In Vitro Diagnostics Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Product (Instruments, Reagents, Software); By Technology (Immunoassay, Molecular Diagnostics, Microbiology); By Application (MRSA, Streptococcus, Clostridium Difficile, VRE, CRE); By Test Location (Point of Care, Central Laboratories); By Region (North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa (MEA))

Published Date: April 2023
Report ID: BWC23324
Available Format: PDF
Page: 400

Report Overview

Rapidly aging population susceptible to infectious diseases and high demand for PoC testing owing to the pandemic are projected to propel the expansion of global infectious disease in vitro diagnostics market during the forecast period between 2023 and 2029.

Global Infectious Disease In Vitro Diagnostics Market- Industry Trends & Forecast Report, 2029

Global infectious disease in vitro diagnostics market size was estimated at USD 35.41 billion in 2022. During the forecast period between 2023 and 2029, the size of global infectious disease in vitro diagnostics market is anticipated to slightly decline at CAGR of -1.38% reaching a value of USD 32.98 billion by 2029. Major growth drivers for global infectious disease in vitro diagnostics market include increasing number of elderly individuals who are vulnerable to contagious illnesses, the COVID-19 pandemic's high requirement for point-of-care testing, greater recognition of the importance of early detection, and the growing occurrence of infectious diseases. The pandemic led to a significant shift in the market, as innovative products for testing SARS-CoV-2 were launched, resulting in substantial growth in the industry in 2020 and 2021. The increased adoption of these products played a crucial role in driving this growth. As a result of the rapid installation of PCR instruments, there has been an opportunity to utilize PCR tests for other infectious diseases, such as influenza, due to the declining need for SARS-CoV-2 tests in 2022. The growing geriatric population is expected to be one of the growth drivers of this market, given that aging is the leading risk factor for the development of diseases such as cardiovascular and neurological diseases.

Global Infectious Disease In Vitro Diagnostics Market – Overview

The infectious disease in vitro diagnostics (IVD) market refers to the use of diagnostic tests and devices to detect and diagnose infectious diseases in biological samples such as blood, urine, and other bodily fluids. These tests are performed in vitro, meaning outside of the body in a laboratory setting. The IVD market for infectious diseases includes a range of tests such as immunoassays, molecular diagnostics, and microbiology culture tests, among others. These tests aid in the identification of infectious agents such as bacteria, viruses, fungi, and parasites, and help in the management and treatment of infectious diseases.

Global Infectious Disease In Vitro Diagnostics Market

Growth Drivers

High Demand for POC Testing Owing to the Pandemic

The global infectious disease in vitro diagnostics market is expected to receive a significant boost due to the high demand for point-of-care (POC) testing, driven by the ongoing pandemic. The need for immediate and accurate testing has led to a surge in demand for POC testing devices, which can provide quick results and aid in the effective management of infectious diseases. As a result, the market for infectious disease in vitro diagnostics is anticipated to experience substantial growth. The pandemic has highlighted the critical importance of efficient and accurate disease diagnosis and management, which is expected to further drive the growth of the infectious disease in vitro diagnostics market.

Growing Geriatric Population Susceptible to Infectious Diseases

The global infectious disease in vitro diagnostics market is expected to be propelled forward by the growing geriatric population, which is particularly susceptible to infectious diseases. With the world's aging population on the rise, the incidence of infectious diseases is also increasing. As a result, there is a growing need for accurate and efficient diagnostic tests to manage these diseases effectively. This is expected to boost the demand for infectious disease in vitro diagnostics devices, which aid in the detection and management of infectious diseases. With technological advancements and increased awareness about early detection and prevention, the infectious disease in vitro diagnostics market is likely to experience significant growth in the coming years, driven in large part by the aging population.

Restraints

High Cost Associated with Testing

The global infectious disease in vitro diagnostics market may face some hindrances due to the high costs associated with testing. While the need for accurate and efficient diagnostic tests is growing, the high cost of these tests can act as a barrier for individuals and healthcare systems. This may lead to a decrease in demand for infectious disease in vitro diagnostics devices, thereby restraining the market's growth. In addition, some low-income countries may not have the resources to invest in expensive diagnostic tests, further limiting the market's growth potential.

Impact of COVID -19 on Global Infectious Disease In Vitro Diagnostics Market

COVID 19 had a positive impact on the infectious disease in vitro diagnostics market. The increased need for detecting cases during the pandemic resulted in higher utilization rates of IVD devices. Regulatory authorities also made testing mandatory to contain the spread of the disease, further driving up demand for IVD devices. However, with the decrease in COVID-19 cases, there may be a decrease in demand for diagnostics. Nonetheless, the infectious disease in vitro diagnostics market is expected to continue growing due to the emergence of new diseases. More people are becoming health-conscious and monitoring their health regularly, which is also contributing to the rise in demand for IVD devices.

Global Infectious Disease In Vitro Diagnostics Market

Segmental Coverage

Global Infectious Disease In Vitro Diagnostics Market – By Product

By product, global infectious disease in vitro diagnostics market is divided into Instruments, Reagents, and Software. The reagents segment held the highest share in the infectious disease in vitro diagnostics market. This was primarily due to the high-volume usage of reagents for conducting tests, as well as the increasing need for COVID-19 testing programs to confirm both positive and negative results. The instruments segment also showed significant growth in 2020 and 2021, mainly due to the increase in PCR instrument installations for SARS-CoV-2 tests. Innovation is rapidly becoming a critical factor in achieving a competitive edge in the market.

Infectious Disease In Vitro Diagnostics Market

Global Infectious Disease In Vitro Diagnostics Market – By Technology

Based on technology, global infectious disease in vitro diagnostics market is divided into Immunoassay, Molecular Diagnostics, and Microbiology. The molecular diagnostics technology segment held the highest shar in the global industry and had the most significant market share. Molecular diagnostics are utilized for detecting major parasitic, bacterial, and viral infections. These tests are sophisticated and address the limitations of traditional testing methods, including inconsistent microorganism growth in manually prepared media, longer turnaround time, and low sensitivity. The immunoassay technology segment is predicted to experience consistent growth at a CAGR rate during the forecast period. As there is a growing need for quick PoC (Point-of-Care) tests, businesses are prioritizing the creation and distribution of immunoassays for COVID-19 detection.

Infectious Disease In Vitro Diagnostics Market Size

Global Infectious Disease In Vitro Diagnostics Market – By Application

Based on application, global infectious disease in vitro diagnostics market is segmented into MRSA, Streptococcus, Clostridium Difficile, VRE, CRE, and Others (Respiratory Virus, Candida, TB And Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19). The COVID-19 application segment was the most dominant segment in the global industry. This can be attributed to the increased utilization of SARS-CoV-2 testing to curb the spread of the virus. Additionally, government initiatives to improve public testing and the launch of innovative products have been significant factors driving the growth of this sector. The TB and HIV segments have also experienced rapid growth due to improved testing methods. Furthermore, the respiratory virus segment's influenza testing has accelerated with the introduction of new diagnostic tests that allow differentiation between SARS-CoV-2 and influenza, facilitating prompt treatment. Tuberculosis, caused by Mycobacterium tuberculosis, is a contagious infection that remains a global epidemic. The WHO reported 130 new cases per 100,000 annually in 2020, but there has been a decline in the incidence rate in recent years, with a 9% drop between 2015 and 2019.

Global Infectious Disease In Vitro Diagnostics Market – By Test Location

Based on test location, global infectious disease in vitro diagnostics market is bifurcated into Point of Care and Central Laboratories segments. In 2022, the central laboratories test location segment held the dominant position in the global industry. Laboratory-based tests are considered more dependable as they offer higher accuracy in comparison to point-of-care tests. Moreover, laboratory tests can conduct complex tests that are not feasible in PoC or homecare settings. In addition, tests that allow patients to collect samples at home and send them to laboratories for testing make the testing process highly convenient. Although there is an increased demand for point-of-care tests to meet faster turnaround times, the COVID-19 pandemic has further boosted the growth of this segment, resulting in heightened demand for such products. The competitive advantage of this sector is due to its rapid turnaround time and low complexity.

Infectious Disease In Vitro Diagnostics Market Share

Global Infectious Disease In Vitro Diagnostics Market – By Region

The in-depth research report on the global infectious disease in vitro diagnostics market covers various country-specific markets across five key regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North America region holds the highest market share and is expected to experience further growth during the forecast period. The key drivers behind North America's success include a well-established diagnostic infrastructure, favorable government regulations, the presence of major companies, and the adoption of advanced technology. During the pandemic, North America was the region most severely impacted, resulting in an increase in the number of tests conducted and technological advancements. In contrast, the Asia-Pacific region is projected to grow at the fastest CAGR during the forecast period, as it has a high incidence of infectious diseases. Japan's growing geriatric population is a significant driver for IVD tests, while India is prone to many infectious diseases. As people become more aware of these diseases, there is a growing demand for tests and diagnostics. As tests are readily available at a low cost, these services are affordable to a large proportion of the population.

Competitive Landscape

Major players operating in global infectious disease in vitro diagnostics market include QIAGEN, BD, bioMérieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen-Probe), Abbott, Quidel Corp., Siemens Healthineers AG, Bio-Rad Laboratories, Inc., Danaher Corp., and OraSure Technologies, Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

In April 2022 - The InspectIR COVID-19 Breathalyzer was approved by the FDA for rapid testing in mobile testing laboratories and doctors' offices, allowing for more accessible testing options.
In February 2022 - SRL Inc. introduced a new laboratory service called "IVD and COVID-19 testing," which accurately confirms negative COVID-19 tests. The instruments segment also showed significant growth in 2020 and 2021, mainly due to the increase in PCR instrument installations for SARS-CoV-2 tests.

Scope of the Report

Attributes	Details
Years Considered	Historical Data – 2019–2022
	Base Year – 2022
	Estimated Year – 2023
	Forecast Period– 2023–2029
Facts Covered	Revenue in USD Billion
Market Coverage	North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Product/ Service Segmentation	Product, Technology, Application, Test Location, Region
Key Players	QIAGEN, BD, bioMérieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen-Probe), Abbott, Quidel Corp., Siemens Healthineers AG, Bio-Rad Laboratories, Inc., Danaher Corp., OraSure Technologies, Inc.

By Product

Instruments
Reagents
Software

By Technology

Immunoassay
Molecular Diagnostics
Microbiology

By Application

MRSA
Streptococcus
Clostridium Difficile
VRE
CRE

By Test Location

Point of Care
Central Laboratories

By Region

North America
Europe
Asia Pacific (APAC)
Latin America
Middle East and Africa (MEA)

Research Framework
1. Research Objective
2. Product Overview
3. Market Segmentation
Executive Summary
Global Infectious Disease In Vitro Diagnostics Market Insights
1. Industry Value Chain Analysis
2. DROC Analysis
  1. Growth Drivers
    1. Growing Geriatric Population Susceptible to Infectious Diseases
    2. High Demand for POC Testing Owing to the Pandemic
  2. Restraints
    1. High Cost Associated with Testing
  3. Opportunities
    1. Rising Prevalence of Infectious Diseases.
  4. Challenges
    1. Lack of Accurate result of Testing
3. Technology Advancements/Recent Developments
4. Regulatory Framework
5. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
Global Infectious Disease In Vitro Diagnostics Market Overview
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Product
    1. Instruments
    2. Reagents
    3. Software
  2. By Technology
    1. Immunoassay
    2. Molecular Diagnostics
    3. Microbiology
    4. Others
  3. By Application
    1. MRSA
    2. Streptococcus
    3. Clostridium Difficile
    4. VRE
    5. CRE
    6. Others (Respiratory Virus, Candida, TB And Drug-resistant TB, Gastro-intestinal Panel Testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B, COVID-19)
  4. By Test Location
    1. Point of Care
    2. Central Laboratories
    3. Others
  5. By Region
    1. North America
    2. Europe
    3. Asia Pacific (APAC)
    4. Latin America (LATAM)
    5. Middle East and Africa (MEA)
North America Infectious Disease In vitro Diagnostics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Product
  2. By Technology
  3. By Application
  4. By Test Location
  5. By Country
    1. United States
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    2. Canada
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
Europe Infectious Disease In vitro Diagnostics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Product
  2. By Technology
  3. By Application
  4. By Test Location
  5. By Country
    1. Germany
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    2. United Kingdom
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    3. Italy
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    4. France
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    5. Spain
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    6. Belgium
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    7. Russia
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    8. The Netherlands
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    9. Rest of Europe
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
Asia-Pacific Infectious Disease In vitro Diagnostics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Product
  2. By Technology
  3. By Application
  4. By Test Location
  5. By Country
    1. China
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    2. India
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    3. Japan
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    4. South Korea
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    5. Australia & New Zealand
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    6. Indonesia
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    7. Malaysia
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    8. Singapore
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    9. Vietnam
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    10. Rest of APAC
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
Latin America Infectious Disease In vitro Diagnostics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Product
  2. By Technology
  3. By Application
  4. By Test Location
  5. By Country
    1. Brazil
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    2. Mexico
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    3. Argentina
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    4. Peru
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    5. Rest of LATAM
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
Middle East & Africa Infectious Disease In vitro Diagnostics Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By Product
  2. By Technology
  3. By Application
  4. By Test Location
  5. By Country
    1. Saudi Arabia
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    2. UAE
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    3. Qatar
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    4. Kuwait
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    5. South Africa
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    6. Nigeria
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    7. Algeria
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
    8. Rest of MEA
      1. By Product
      2. By Technology
      3. By Application
      4. By Test Location
Competitive Landscape
1. List of Key Players and Their Offerings
2. Global Infectious Disease In Vitro Diagnostics Company Market Share Analysis, 2022
3. Competitive Benchmarking, By Operating Parameters
4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
Impact of Covid-19 on Global Infectious Disease In Vitro Diagnostics Market
Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
1. QIAGEN
2. BD
3. bioMérieux SA
4. F. Hoffmann-La Roche, Ltd.
5. Hologic, Inc. (Gen-Probe)
6. Abbott
7. Quidel Corp.
8. Siemens Healthineers AG
9. Bio-Rad Laboratories, Inc.
10. Danaher Corp.
11. OraSure Technologies, Inc.
12. Other Prominent Players
Key Strategic Recommendations
Research Methodology
1. Qualitative Research
  1. Primary & Secondary Research
2. Quantitative Research
3. Market Breakdown & Data Triangulation
  1. Secondary Research
  2. Primary Research
4. Breakdown of Primary Research Respondents, By Region
5. Assumptions & Limitations

*Financial information of case of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1 Global Infectious Disease In Vitro Diagnostics Segmentation

Figure 2 Global Infectious Disease In Vitro Diagnostics Market Value Chain Analysis

Figure 3 Company Market Share Analysis, 2022

Figure 4 Global Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 5 Global Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 6 Global Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 7 Global Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 8 Global Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 9 Global Infectious Disease In Vitro Diagnostics Market Share, By Region, By Value, 2019–2029

Figure 10 North America Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 11 North America Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 12 North America Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 13 North America Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 14 North America Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 15 North America Infectious Disease In Vitro Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 16 United States Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 17 United States Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 18 United States Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 19 United States Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 20 United States Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 21 Canada Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 22 Canada Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 23 Canada Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 24 Canada Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 25 Canada Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 26 Europe Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 27 Europe Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 28 Europe Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 29 Europe Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 30 Europe Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 31 Europe Infectious Disease In Vitro Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 32 Germany Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 33 Germany Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 34 Germany Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 35 Germany Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 36 Germany Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 37 United Kingdom Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 38 United Kingdom Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 39 United Kingdom Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 40 United Kingdom Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 41 United Kingdom Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 42 Italy Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 43 Italy Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 44 Italy Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 45 Italy Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 46 Italy Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 47 France Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 48 France Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 49 France Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 50 France Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 51 France Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 52 Spain Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 53 Spain Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 54 Spain Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 55 Spain Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 56 Spain Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 57 Belgium Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 58 Belgium Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 59 Belgium Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 60 Belgium Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 61 Belgium Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 62 Russia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 63 Russia Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 64 Russia Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 65 Russia Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 66 Russia Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 67 The Netherlands Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 68 The Netherlands Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 69 The Netherlands Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 70 The Netherlands Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 71 Rest of Europe Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 72 Rest of Europe Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 73 Rest of Europe Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 74 Rest of Europe Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 75 Rest of Europe Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 76 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 77 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 78 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 79 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 80 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 81 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 82 China Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 83 China Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 84 China Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 85 China Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 86 China Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 87 India Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 88 India Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 89 India Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 90 India Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 91 India Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 92 Japan Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 93 Japan Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 94 Japan Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 95 Japan Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 96 Japan Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 97 South Korea Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 98 South Korea Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 99 South Korea Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 100 South Korea Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 101 South Korea Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 102 Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 103 Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 104 Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 105 Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 106 Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 107 Indonesia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 108 Indonesia Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 109 Indonesia Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 110 Indonesia Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 111 Indonesia Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 112 Malaysia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 113 Malaysia Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 114 Malaysia Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 115 Malaysia Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 116 Malaysia Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 117 Singapore Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 118 Singapore Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 119 Singapore Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 120 Singapore Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 121 Singapore Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 122 Vietnam Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 123 Vietnam Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 124 Vietnam Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 125 Vietnam Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 126 Vietnam Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 127 Rest of APAC Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 128 Rest of APAC Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 129 Rest of APAC Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 130 Rest of APAC Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 131 Rest of APAC Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 132 Latin America Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 133 Latin America Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 134 Latin America Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 135 Latin America Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 136 Latin America Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 137 Latin America Infectious Disease In Vitro Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 138 Brazil Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 139 Brazil Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 140 Brazil Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 141 Brazil Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 142 Brazil Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 143 Mexico Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 144 Mexico Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 145 Mexico Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 146 Mexico Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 147 Mexico Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 148 Argentina Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 149 Argentina Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 150 Argentina Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 151 Argentina Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 152 Argentina Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 153 Peru Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 154 Peru Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 155 Peru Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 156 Peru Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 157 Peru Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 158 Rest of LATAM Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 159 Rest of LATAM Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 160 Rest of LATAM Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 161 Rest of LATAM Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 162 Rest of LATAM Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 163 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 164 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 165 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 166 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 167 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 168 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Share, By Country, By Value, 2019–2029

Figure 169 Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 170 Saudi Arabia Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 171 Saudi Arabia Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 172 Saudi Arabia Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 173 Saudi Arabia Infectious Disease In Vitro Diagnostics Market Share, By Distriibution Application, By Value, 2019–2029

Figure 174 UAE Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 175 UAE Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 176 UAE Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 177 UAE Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 178 UAE Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 179 Qatar Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 180 Qatar Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 181 Qatar Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 182 Qatar Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 183 Qatar Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 184 Kuwait Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 185 Kuwait Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 186 Kuwait Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 187 Kuwait Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 188 Kuwait Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 189 South Africa Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 190 South Africa Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 191 South Africa Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 192 South Africa Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 193 South Africa Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 194 Nigeria Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 195 Nigeria Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 196 Nigeria Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 197 Nigeria Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 198 Nigeria Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 199 Algeria Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 200 Algeria Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 201 Algeria Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 202 Algeria Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 203 Algeria Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

Figure 204 Rest of MEA Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Figure 205 Rest of MEA Infectious Disease In Vitro Diagnostics Market Share, By Product, By Value, 2019–2029

Figure 206 Rest of MEA Infectious Disease In Vitro Diagnostics Market Share, By Technology, By Value, 2019–2029

Figure 207 Rest of MEA Infectious Disease In Vitro Diagnostics Market Share, By Application, By Value, 2019–2029

Figure 208 Rest of MEA Infectious Disease In Vitro Diagnostics Market Share, By Test Location, By Value, 2019–2029

List of Tables

Table 1 Global Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 2 Global Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 3 Global Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 4 Global Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 5 Global Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 6 Global Infectious Disease In Vitro Diagnostics Market Size, By Region, By Value, 2019–2029

Table 7 North America Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 8 North America Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 9 North America Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 10 North America Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 11 North America Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 12 North America Infectious Disease In Vitro Diagnostics Market Size, By Country, By Value, 2019–2029

Table 13 United States Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 14 United States Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 15 United States Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 16 United States Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 17 United States Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 18 Canada Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 19 Canada Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 20 Canada Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 21 Canada Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 22 Canada Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 23 Europe Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 24 Europe Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 25 Europe Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 26 Europe Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 27 Europe Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 28 Europe Infectious Disease In Vitro Diagnostics Market Size, By Country, By Value, 2019–2029

Table 29 Germany Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 30 Germany Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 31 Germany Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 32 Germany Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 33 Germany Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 34 United Kingdom Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 35 United Kingdom Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 36 United Kingdom Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 37 United Kingdom Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 38 United Kingdom Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 39 Italy Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 40 Italy Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 41 Italy Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 42 Italy Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 43 Italy Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 44 France Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 45 France Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 46 France Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 47 France Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 48 France Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 49 Spain Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 50 Spain Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 51 Spain Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 52 Spain Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 53 Spain Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 54 Belgium Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 55 Belgium Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 56 Belgium Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 57 Belgium Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 58 Belgium Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 59 Russia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 60 Russia Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 61 Russia Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 62 Russia Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 63 Russia Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 64 The Netherlands Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 65 The Netherlands Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 66 The Netherlands Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 67 The Netherlands Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 68 Rest of Europe Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 69 Rest of Europe Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 70 Rest of Europe Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 71 Rest of Europe Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 72 Rest of Europe Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 73 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 74 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 75 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 76 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 77 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 78 Asia-Pacific Infectious Disease In Vitro Diagnostics Market Size, By Country, By Value, 2019–2029

Table 79 China Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 80 China Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 81 China Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 82 China Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 83 China Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 84 India Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 85 India Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 86 India Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 87 India Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 88 India Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 89 Japan Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 90 Japan Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 91 Japan Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 92 Japan Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 93 Japan Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 94 South Korea Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 95 South Korea Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 96 South Korea Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 97 South Korea Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 98 South Korea Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 99 Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 100 Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 101 Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 102 Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 103 Australia & New Zealand Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 104 Indonesia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 105 Indonesia Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 106 Indonesia Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 107 Indonesia Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 108 Indonesia Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 109 Malaysia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 110 Malaysia Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 111 Malaysia Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 112 Malaysia Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 113 Malaysia Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 114 Singapore Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 115 Singapore Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 116 Singapore Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 117 Singapore Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 118 Singapore Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 119 Vietnam Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 120 Vietnam Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 121 Vietnam Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 122 Vietnam Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 123 Vietnam Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 124 Rest of APAC Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 125 Rest of APAC Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 126 Rest of APAC Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 127 Rest of APAC Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 128 Rest of APAC Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 129 Latin America Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 130 Latin America Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 131 Latin America Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 132 Latin America Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 133 Latin America Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 134 Latin America Infectious Disease In Vitro Diagnostics Market Size, By Country, By Value, 2019–2029

Table 135 Brazil Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 136 Brazil Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 137 Brazil Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 138 Brazil Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 139 Brazil Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 140 Mexico Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 141 Mexico Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 142 Mexico Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 143 Mexico Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 144 Mexico Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 145 Argentina Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 146 Argentina Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 147 Argentina Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 148 Argentina Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 149 Argentina Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 150 Peru Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 151 Peru Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 152 Peru Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 153 Peru Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 154 Peru Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 155 Rest of LATAM Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 156 Rest of LATAM Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 157 Rest of LATAM Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 158 Rest of LATAM Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 159 Rest of LATAM Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 160 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 161 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 162 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 163 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 164 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 165 Middle East & Africa Infectious Disease In Vitro Diagnostics Market Size, By Country, By Value, 2019–2029

Table 166 Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 167 Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 168 Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 169 Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 170 Saudi Arabia Infectious Disease In Vitro Diagnostics Market Size, By Distriibution Application, By Value, 2019–2029

Table 171 UAE Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 172 UAE Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 173 UAE Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 174 UAE Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 175 UAE Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 176 Qatar Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 177 Qatar Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 178 Qatar Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 179 Qatar Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 180 Qatar Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 181 Kuwait Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 182 Kuwait Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 183 Kuwait Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 184 Kuwait Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 185 Kuwait Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 186 South Africa Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 187 South Africa Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 188 South Africa Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 189 South Africa Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 190 South Africa Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 191 Nigeria Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 192 Nigeria Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 193 Nigeria Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 194 Nigeria Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 195 Nigeria Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 196 Algeria Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 197 Algeria Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 198 Algeria Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 199 Algeria Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 200 Algeria Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 201 Rest of MEA Infectious Disease In Vitro Diagnostics Market Size, By Value (USD Million), 2019–2029

Table 202 Rest of MEA Infectious Disease In Vitro Diagnostics Market Size, By Product, By Value, 2019–2029

Table 203 Rest of MEA Infectious Disease In Vitro Diagnostics Market Size, By Technology, By Value, 2019–2029

Table 204 Rest of MEA Infectious Disease In Vitro Diagnostics Market Size, By Application, By Value, 2019–2029

Table 205 Rest of MEA Infectious Disease In Vitro Diagnostics Market Size, By Test Location, By Value, 2019–2029

Table 206 QIAGEN Company Overview

Table 207 QIAGEN Financial Overview

Table 208 BD Company Overview

Table 209 BD Financial Overview

Table 210 bioMérieux SA Company Overview

Table 211 bioMérieux SA Financial Overview

Table 212 F. Hoffmann-La Roche, Ltd. Company Overview

Table 213 F. Hoffmann-La Roche, Ltd. Financial Overview

Table 214 Hologic, Inc. (Gen-Probe) Company Overview

Table 215 Hologic, Inc. (Gen-Probe) Financial Overview

Table 216 Abbott Company Overview

Table 217 Abbott Financial Overview

Table 218 Quidel Corp. Company Overview

Table 219 Quidel Corp. Financial Overview

Table 220 Siemens Healthineers AG Company Overview

Table 221 Siemens Healthineers AG Financial Overview

Table 222 Bio-Rad Laboratories, Inc. Company Overview

Table 223 Bio-Rad Laboratories, Inc. Financial Overview

Table 224 Danaher Corp. Company Overview

Table 225 Danaher Corp. Financial Overview

Table 226 OraSure Technologies, Inc. Company Overview

Table 227 OraSure Technologies, Inc. Financial Overview

Market Segmentation

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

1. Which segment accounts for the highest market share in the Global Infectious Disease In Vitro Diagnostics Market by technology?

Ans: The molecular diagnostics segment is expected to hold the highest market share in the Global Infectious Disease In Vitro Diagnostics Market by technology.

2. Which segment accounts for the highest market share in the Global Infectious Disease In Vitro Diagnostics Market by product?

Ans: The reagent segment is expected to hold the highest market share in the Global Infectious Disease In Vitro Diagnostics Market by product.

3. What is the current market size of Global Infectious Disease In Vitro Diagnostics Market?

Ans: In 2022, the Global Infectious Disease In Vitro Diagnostics Market size was estimated at USD 35.41 billion in 2022.

4. What are the major factors driving the growth of Global Infectious Disease In Vitro Diagnostics Market?

Ans: Major factors driving the growth of Global Infectious Disease In Vitro Diagnostics Market include growing geriatric population susceptible to infectious diseases and high demand for PoC testing owing to the pandemic.

5. Name the key players in Global Infectious Disease In Vitro Diagnostics Market.

Ans: Key players in Global Infectious Disease In Vitro Diagnostics Market include QIAGEN, BD, bioMérieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen-Probe), Abbott, Quidel Corp., Siemens Healthineers AG, Bio-Rad Laboratories, Inc., Danaher Corp., and OraSure Technologies, Inc.

PLACE AN ORDER

SINGLE USER LICENSE
$ 4850
GROUP LICENSE
$ 5750
ENTERPRISE LICENSE
$ 8150
EXCEL DATA PACK
$ 3250

Request for Sample

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Custom Research Service

Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy

Ask the Analyst to customize an exclusive study to serve your research needs
Data Visualization

As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.

Infectious Disease In Vitro Diagnostics Market

Report Overview

Market Segmentation

To request a free sample copy of this report, please complete the form below.

Frequently Asked Questions (FAQs):

1. Which segment accounts for the highest market share in the Global Infectious Disease In Vitro Diagnostics Market by technology?

2. Which segment accounts for the highest market share in the Global Infectious Disease In Vitro Diagnostics Market by product?

3. What is the current market size of Global Infectious Disease In Vitro Diagnostics Market?

4. What are the major factors driving the growth of Global Infectious Disease In Vitro Diagnostics Market?

5. Name the key players in Global Infectious Disease In Vitro Diagnostics Market.

PLACE AN ORDER

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Custom Research Service

Quality & Accuracy

Data Visualization

Information security